Clinical Trial Detail

NCT ID NCT01619761
Title Natural Killer (NK) Cells in Cord Blood Transplantation
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

hematologic cancer

Therapies

Rituximab

Fludarabine + Lenalidomide + Melphalan

Mycophenolate mofetil

Tacrolimus

Age Groups: adult senior

No variant requirements are available.